Ion Channel Screening
Whether you want to explore an ion channel as a potential new target or understand cardiovascular, CNS and other liabilities, ApconiX can help you with our electrophysiology expertise, customer-focused flexibility and rapid delivery of high data quality. The services we offer include hERG screening and CiPA assays, a CNS panel of 15 ion channels and a MicroElectrode Array assay using human derived neuronal stem cells. These are complemented by a wide range of assay development and ion channel screening services.
Make safety part of drug design with early drug discovery screening.
Rapid high quality ion channel screening
for hERG and the CiPA paradigm
An integrated in vitro screening approach for seizure liability to support hazard identification and decision making in early drug discovery
Including assay development, manual patch clamp, sustainability and investigative research.
ApconiX now offers screening
of analgesic compounds in
human iPSC sensory neurons.
Director and co-founder Dr Michael Morton and Dr Kimberly Rockley discuss the benefits of early ion channel screening in this DDW podcast